Freestone Grove Partners’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4M Buy
1,602,569
+1,093,633
+215% +$15.4M 0.13% 219
2025
Q4
$7.31M Buy
+508,936
New +$8.8M 0.05% 318

Other funds holding OSCR

Freestone Grove Partners's OSCR Position: Q1 2026 in Review

Freestone Grove Partners increased its Oscar Health (OSCR) stake by 215% in Q1 2026, buying an estimated $15.4M and bringing the position to 1,602,569 shares worth $18.4M. The position accounts for 0.13% of the portfolio, ranked #219.

Freestone Grove Partners first reported a position in OSCR in Q4 2025 and has held it in 2 quarters since. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Freestone Grove Partners held 1,602,569 shares of Oscar Health worth $18.4M as of Q1 2026.
  • Freestone Grove Partners bought 1,093,633 Oscar Health shares in Q1 2026, an estimated $15.4M.
  • Oscar Health made up 0.13% of Freestone Grove Partners's portfolio in Q1 2026, its #219 holding.
  • Freestone Grove Partners first reported a position in Oscar Health in Q4 2025 and has held it in 2 quarters since.
  • 330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.